pharmaceutical Logo

Working At Gilead Palo Alto

Zippia Score 4.2

Gilead Palo Alto overview

Gilead Palo Alto, Inc. develops and commercializes small molecule drugs for the treatment of cardiovascular diseases. It develops advances in molecular biology and genetics to identify mechanisms of cardiovascular diseases and targets for drug discovery. The company offers Ranexa (ranolazine extended-release tablets), which is used for the treatment of chronic angina; and Lexiscan (regadenoson) injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI). Its products under clinical development comprise Tecadenoson, which is in Phase III clinical trials product for the potential reduction of rapid heart rate during acute atrial arrhythmias, and in Phase II clinical trials for acute atrial fibrillation; Adentri, a Phase III clinical studies product for heart failure; CVT-6883, a Phase I clinical trial product to treat cardiopulmonary diseases; and CVT-3619, a Phase I clinical studies drug for diabetes/metabolic syndrome. The company s products under preclinical trials include Tecadenoson for atrial fibrillation; CVT-10,216 to treat alcohol addicted patients; Late I for the treatment of coronary artery disease; A2A antagonist for chemical dependence; ABCA1/ApoA-I to treat atherosclerosis; and Drug-Eluting Stent Program for the treatment of restenosis. The company has collaborative partnerships with Biogen Idec Inc.; Astellas Pharma, Inc.; Menarini Group; and Roche Palo Alto LLC. Gilead Palo Alto, Inc. was formerly known as CV Therapeutics, Inc. and changed its name to Gilead Palo Alto, Inc. in January 2009. The company was incorporated in 1990 and is based in Foster City, California. As of April 14, 2009, Gilead Palo Alto, Inc. operates as a subsidiary of Gilead Sciences Inc.
The average employee at Gilead Palo Alto makes $55,954 per year. Pay at Gilead Palo Alto is significantly lower than some of its highest paying competitors, like Evelo Biosciences, Rigel Pharmaceuticals, and NGM BIOPHARMACEUTICALS, which pay $93,161, $89,730, and $86,969, respectively.
Based in the United States, Gilead Palo Alto is a medium-sized pharmaceutical company with 550 employees.

The Organization’s Mission

To advance the care of patients suffering from life-threatening diseases worldwide.

Industry

Pharmaceutical

Revenue

-

Employees

550

Founded in

1990

Headquarters

-

Website

-

Website

-

Organization Type

-

Is This Your Company?

The team at Gilead Palo Alto

What do people say about Gilead Palo Alto

Work at Gilead Palo Alto ? Share your experience anonymously.

What do you like about working for Gilead Palo Alto?

Gilead Palo Alto Salaries

How much does Gilead Palo Alto pay?
The national average salary for a Gilead Palo Alto employee in the United States is $65,763 per year. Employees in the top 10 percent can make over $89,000 per year, while employees at the bottom 10 percent earn less than $48,000 per year.
9.2
Salary Score
Average Employee Earnings

Gilead Palo Alto Salaries By Job Title

While Gilead Palo Alto employees earn an average yearly salary of $65,763, different roles can command different wages. The higher paying positions at Gilead Palo Alto include Clinical Program Manager, Senior Research Associate, Associate Scientist, and Research Scientist. A typical Clinical Program Manager salary at Gilead Palo Alto is $79,154.
00

Do you Work At Gilead Palo Alto?

Help us make this company more transparent.

0

Gilead Palo Alto Financial Performance

8.3
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Revenue

-

Founded in

1990

Organization type

-

How Would You Rate The Company Culture Of Gilead Palo Alto?

Have you worked at Gilead Palo Alto? Help other job seekers by rating Gilead Palo Alto.

Gilead Palo Alto Competitors

Based on our research, similar companies to Gilead Palo Alto are Intellia Therapeutics, Achaogen, and Rigel Pharmaceuticals, Inc.. The wages at Intellia Therapeutics average higher than the other similar companies, where the median salary is $89,995 per year. The employees at Achaogen earn an average yearly salary of $83,224 per year, and the salaries at Rigel Pharmaceuticals, Inc. average $81,122 per year.

Frequently Asked Questions about Gilead Palo Alto

When was Gilead Palo Alto founded?

Gilead Palo Alto was founded in 1990.

How many Employees does Gilead Palo Alto have?

Gilead Palo Alto has 550 employees.

What industry is Gilead Palo Alto in?

Gilead Palo Alto is in the pharmaceutical industry.

What is Gilead Palo Alto's mission?

Gilead Palo Alto's mission statement is "To advance the care of patients suffering from life-threatening diseases worldwide."

Who are Gilead Palo Alto's competitors?

Gilead Palo Alto competitors include Editas Medicine, BioReliance, Achaogen, aTyr Pharma, Surface Logix, Dicerna Pharmaceuticals, Jounce Therapeutics, Ocimum Biosolutions, Portola Pharmaceuticals, Celldex Therapeutics, PTC Therapeutics, Ricerca Biosciences, Momenta Pharmaceuticals, Cytokinetics, Paratek Pharmaceuticals, Agouron Pharmaceuticals, Alnylam Pharmaceuticals, Constellation Pharmaceuticals, Idenix Pharmaceuticals, ARIAD Pharmaceuticals.

Are you an executive, HR leader, or brand manager at Gilead Palo Alto?

Claiming and updating your company profile on Zippia is free and easy.

You can find out what it is like to work at Gilead Palo Alto, also known as GILEAD PALO ALTO INC, Gilead Palo Alto Inc and Gilead Palo Alto, Inc..

Zippia gives an in-depth look into the details of Gilead Palo Alto, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Gilead Palo Alto. The employee data is based on information from people who have self-reported their past or current employments at Gilead Palo Alto. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Gilead Palo Alto and its employees or that of Zippia.